Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01663259
Title Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Avraham Eisbruch
Indications

oropharynx cancer

Therapies

Cetuximab

Age Groups: adult
Covered Countries USA


No variant requirements are available.